Risk Factors for Mitral Valve Surgery: Atrial Fibrillation and Pulmonary Hypertension

Nkomo VT Gardin JM Skelton TN Gottdiener JS Scott CG Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005-1011. doi:10.1016/S0140-6736(06)69208-8

Laslett LJ Alagona P Jr Clark BA III et al . The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. J Am Coll Cardiol. 2012;60(25 suppl):S1-S49. doi:10.1016/j.jacc.2012.11.002

Nishimura RA Otto CM Bonow RO et al . 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2017;135:e1159-e1195. doi:10.1161/CIR.0000000000000503

Baumgartner H Falk V Bax JJ et al . 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739-2791. doi:10.1093/ejcts/ezx324

Brand FN Abbott RD Kannel WB Wolf PA. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study. JAMA. 1985;254:3449-3453.

Wolf PA Abbott RD Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-988. doi:10.1161/01.STR.22.8.983

Albertsen IE Rasmussen LH Overvad TF Graungaard T Larsen TB Lip GYH . Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis. Stroke. 2013;44:1329-1336. doi:10.1161/STROKEAHA.113.000883

Wolf PA Dawber TR Thomas HE Jr Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study. Neurology. 1978;28:973-977.

Gillinov M Soltesz EG. Atrial fibrillation in the patient undergoing mitral valve surgery: a once-in-a-lifetime opportunity. J Thorac Cardiovasc Surg. 2018;155:995-996. doi:10.1016/j.jtcvs.2017.09.125

Udesh R Solanki P Mehta A Gleason T Wechsler L Thirumala PD. Carotid artery stenosis as an independent risk factor for perioperative strokes following mitral valve surgical intervention. J Neurol Sci. 2017;382:170-184. doi:10.1016/j.jns.2017.10.004

Alexiou C Doukas G Oc M et al . The effect of preoperative atrial fibrillation on survival following mitral valve repair for degenerative mitral regurgitation. Eur J Cardiothoracic Surg. 2007;31:586-591. doi:10.1016/j.ejcts.2006.12.039

Eguchi K Ohtaki E Matsumura T et al . Pre-operative atrial fibrillation as the key determinant of outcome of mitral valve repair for degenerative mitral regurgitation. Eur Heart J. 2005;26:1866-1872. doi:10.1093/eurheartj/ehi272

January CT Wann LS Alpert JS et al . 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130:2071-2104. doi:10.1161/CIR.0000000000000040

Fauchier L Philippart R Clementy N et al . How to define valvular atrial fibrillation? Arch Cardiovasc Dis. 2015;108:530-539. doi:10.1016/j.acvd.2015.06.002

Burstein B Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008;51:802-809. doi:10.1016/j.jacc.2007.09.064

Vaziri SM Larson MG Benjamin EJ Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 1994;89:724-730.

Psaty BM Manolio TA Kuller LH et al . Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96:2455-2461. doi:10.1161/01.CIR.96.7.2455

Kim HJ Kim JB Jung SH Choo SJ Chung CH Lee JW. Surgical ablation of atrial fibrillation in patients with a giant left atrium undergoing mitral valve surgery. Heart. 2016;102:1206-1214. doi:10.1136/heartjnl-2015-308482

Ishii Y Sakamoto S-I Miyagi Y Kawase Y Otsuka T Nitta T. Risk factors of recurrence of atrial fibrillation after AF surgery in patients with AF and mitral valve disease. Semin Thorac Cardiovasc Surg. 2018;30:271-278. doi:10.1053/j.semtcvs.2018.01.004

Reed D Abbott RD Smucker ML Kaul S. Prediction of outcome after mitral valve replacement in patients with symptomatic chronic mitral regurgitation: the importance of left atrial size. Circulation. 1991;84:23-34. doi:10.1161/01.CIR.84.1.23

Thamilarasan M Klein AL. Factors relating to left atrial enlargement in atrial fibrillation: “chicken or the egg” hypothesis. Am Heart J. 1999;137:381-383.

Liang JJ Silvestry FE. Mechanistic insights into mitral regurgitation due to atrial fibrillation: “atrial functional mitral regurgitation.” Trends Cardiovasc Med. 2016;26:681-689. doi:10.1016/j.tcm.2016.04.012

Medi C Kalman JM Haqqani H et al . Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. J Am Coll Cardiol. 2009;53:1791-1797. doi:10.1016/j.jacc.2009.02.014

Ju W Yang B Li M et al . Tachycardiomyopathy complicated by focal atrial tachycardia: incidence, risk factors, and long-term outcome. J Cardiovasc Electrophysiol. 2014;25:953-957. doi:10.1111/jce.12428

Kang KT Etheridge SP Kantoch MJ et al . Current management of focal atrial tachycardia in children: a multicenter experience. Circ Arrhythm Electrophysiol. 2014;7:664-670. doi:10.1161/CIRCEP.113.001423

Nerheim P Birger-Botkin S Piracha L Olshansky B. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia. Circulation. 2004;110:247-252. doi:10.1161/01.CIR.0000135472.28234.CC

Calò L De Ruvo E Sette A et al . Tachycardia-induced cardiomyopathy: mechanisms of heart failure and clinical implications. J Cardiovasc Med (Hagerstown). 2007;8:138-143. doi:10.2459/01.JCM.0000260841.30415.62

Ferreira JP Santos M. Heart failure and atrial fibrillation: from basic science to clinical practice. Int J Mol Sci. 2015;16:3133-3147. doi:10.3390/ijms16023133

Nedios S Sommer P Dagres N et al . Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function: the importance of rhythm and rate control. Heart Rhythm. 2014;11:344-351. doi:10.1016/j.hrthm.2013.12.031

Cha YM Redfield MM Shen WK Gersh BJ. Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle. Circulation. 2004;109:2839-2843. doi:10.1161/01.CIR.0000132470.78896.A8

Gertz ZM Raina A Saghy L et al . Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. J Am Coll Cardiol. 2011;58:1474-1481. doi:10.1016/j.jacc.2011.06.032

Asgar AW Mack MJ Stone GW. Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol. 2015;65:1231-1248. doi:10.1016/j.jacc.2015.02.009

Ogata T Matsuo R Kiyuna F et al . Left atrial size and long-term risk of recurrent stroke after acute ischemic stroke in patients with nonvalvular atrial fibrillation. J Am Heart Assoc. 2017;6:e006402. doi:10.1161/JAHA.117.006402

Liles JP Wanderling C Liles JL et al . Pre-existence of prothrombotic state in patients with atrial fibrillation despite therapy with new and traditional anti-coagulant drugs. Blood. 2015;126:4731.

Weymann A Sabashnikov A Ali-Hasan-Al-Saegh S et al . Predictive role of coagulation, fibrinolytic, and endothelial markers in patients with atrial fibrillation, stroke, and thromboembolism: a meta-analysis, meta-regression, and systematic review. Med Sci Monit Basic Res. 2017;23:97-140. doi:10.12659/MSMBR.902558

Wu N Tong S Xiang Y et al . Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression. PLoS One. 2015;10:e0124716. doi:10.1371/journal.pone.0124716

De Marco M Gerdts E Casalnuovo G et al . Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE study. Am J Hypertens. 2013;26:567-573. doi:10.1093/ajh/hps082

Iung B Leenhardt A Extramiana F. Management of atrial fibrillation in patients with rheumatic mitral stenosis. Heart. 2018;104:1062-1068. doi:10.1136/heartjnl-2017-311425

Nishimura RA Otto CM Bonow RO et al . 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation. 2014;129:e521-e643. doi:10.1161/CIR.0000000000000031

Hart RG Pearce LA Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-867.

Ad N Holmes SD Massimiano PS Rongione AJ Fornaresio LM. Long-term outcome following concomitant mitral valve surgery and Cox maze procedure for atrial fibrillation. J Thorac Cardiovasc Surg. 2018;155:983-994. doi:10.1016/j.jtcvs.2017.09.147

Badhwar V Rankin JS Damiano RJ Jr et al . The Society of Thoracic Surgeons 2017 clinical practice guidelines for the surgical treatment of atrial fibrillation. Ann Thorac Surg. 2017;103:329-341. doi:10.1016/j.athoracsur.2016.10.076

Kirchhof P Benussi S Kotecha D et al . 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609-1678. doi:10.1093/europace/euw295

Jessurun ER van Hemel NM Kelder JC et al . Mitral valve surgery and atrial fibrillation: is atrial fibrillation surgery also needed? Eur J Cardiothoracic Surg. 2000;17:530-537.

Je HG Shuman DJ Ad N. A systematic review of minimally invasive surgical treatment for atrial fibrillation: a comparison of the Cox-Maze procedure, beating-heart epicardial ablation, and the hybrid procedure on safety and efficacy. Eur J Cardiothoracic Surg. 2015;48:531-541. doi:10.1093/ejcts/ezu536

Badhwar V Rankin JS Ad N et al . Surgical ablation of atrial fibrillation in the United States: trends and propensity matched outcomes. Ann Thorac Surg. 2017;104:493-500. doi:10.1016/j.athoracsur.2017.05.016

Tsai YC Phan K Munkholm-Larsen S Tian DH La Meir M Yan TD. Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis. Eur J Cardiothoracic Surg. 2015;47:847-854. doi:10.1093/ejcts/ezu291

Kanderian AS Gillinov AM Pettersson GB Blackstone E Klein AL. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol. 2008;52:924-929. doi:10.1016/j.jacc.2008.03.067

Huffman MD Karmali KN Berendsen MA et al . Concomitant atrial fibrillation surgery for people undergoing cardiac surgery. Cochrane Database Syst Rev. 2016;(8):CD011814. doi:10.1002/14651858.CD011814.pub2

Katz ES Tsiamtsiouris T Applebaum RM Schwartzbard A Tunick PA Kronzon I. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiographic study. J Am Coll Cardiol. 2000;36:468-471. doi:10.1016/S0735-1097(00)00765-8

Badheka AO Chothani A Mehta K et al . Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volume. Circ Arrhythm Electrophysiol. 2015;8:42-48. doi:10.1161/CIRCEP.114.001413

Turagam MK Vuddanda V Verberkmoes N et al . Epicardial left atrial appendage exclusion reduces blood pressure in patients with atrial fibrillation and hypertension. J Am Coll Cardiol. 2018;72:1346-1353. doi:10.1016/j.jacc.2018.06.066

Walls MC Cimino N Bolling SF Bach DS. Persistent pulmonary hypertension after mitral valve surgery: does surgical procedure affect outcome? J Heart Valve Dis. 2008;17:1-9.

Le Tourneau T Richardson M Juthier F et al . Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart. 2010;96:1311-1317. doi:10.1136/hrt.2009.186486

Ghoreishi M Evans CF DeFilippi CR et al . Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. J Thorac Cardiovasc Surg. 2011;142:1439-1452. doi:10.1016/j.jtcvs.2011.08.030

Mentias A Patel K Patel H et al . Effect of pulmonary vascular pressures on long-term outcome in patients with primary mitral regurgitation. J Am Coll Cardiol. 2016;67:2952-2961. doi:10.1016/j.jacc.2016.03.589

Nashef SAM Roques F Sharples LD et al . EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734-745. doi:10.1093/ejcts/ezs043

Di Mauro M Calafiore AM Penco M Romano S Di Giammarco G Gallina S. Mitral valve repair for dilated cardiomyopathy: predictive role of right ventricular dysfunction. Eur Heart J. 2007;28:2510-2516. doi:10.1093/eurheartj/ehm375

Di Mauro M Foschi M Tancredi F et al . Additive and independent prognostic role of abnormal right ventricle and pulmonary hypertension in mitral-tricuspid surgery. Int J Cardiol. 2018;252:39-43. doi:10.1016/j.ijcard.2017.11.031

Patel H Desai M Tuzcu EM Griffin B Kapadia S. Pulmonary hypertension in mitral regurgitation. J Am Heart Assoc. 2014;3:e000748. doi:10.1161/JAHA.113.000748

Magne J Pibarot P Sengupta PP Donal E Rosenhek R Lancellotti P. Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group. JACC Cardiovasc Imaging. 2015;8:83-99. doi:10.1016/j.jcmg.2014.12.003

McLaughlin VV Archer SL Badesch DB et al . ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009;119:2250-2294. doi:10.1161/CIRCULATIONAHA.109.192230

Snopek G Pogorzelska H Rywik TM Browarek A Janas J Korewicki J. Usefulness of endothelin-1 concentration in capillary blood in patients with mitral stenosis as a predictor of regression of pulmonary hypertension after mitral valve replacement or valvuloplasty. Am J Cardiol. 2002;90:188-189.

Noordegraaf AV Westerhof BE Westerhof N. The relationship between the right ventricle and its load in pulmonary hypertension. J Am Coll Cardiol. 2017;69:236-243. doi:10.1016/j.jacc.2016.10.047

Ryan JJ Archer SL. The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure. Circ Res. 2014;115:176-188. doi:10.1161/CIRCRESAHA.113.301129

Archer SL Fang YH Ryan JJ Piao L. Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension. Pulm Circ. 2013;3:144-152. doi:10.4103/2045-8932.109960

Galiè N Humbert M Vachiery JL et al . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67-119. doi:10.1093/eurheartj/ehv317

Guazzi M Naeije R. Pulmonary hypertension in heart failure: pathophysiology, pathobiology, and emerging clinical perspectives. J Am Coll Cardiol. 2017;69:1718-1734. doi:10.1016/j.jacc.2017.01.051

Stevenson LW Bellil D Grover-McKay M et al . Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1987;60:654-658.

Tumminello G Lancellotti P Lempereur M D’Orio V Pierard LA. Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure. Eur Heart J. 2007;28:569-574. doi:10.1093/eurheartj/ehl561

Gerges C Gerges M Lang MB et al . Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in “out-of-proportion” pulmonary hypertension. Chest. 2013;143:758-766. doi:10.1378/chest.12-1653

Yock PG Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation. 1984;70:657-662.

Roberts JD Forfia PR. Diagnosis and assessment of pulmonary vascular disease by Doppler echocardiography. Pulm Circ. 2011;1:160-181. doi:10.4103/2045-8932.83446

Yared K Noseworthy P Weyman AE McCabe E Picard MH Baggish AL. Pulmonary artery acceleration time provides an accurate estimate of systolic pulmonary arterial pressure during transthoracic echocardiography. J Am Soc Echocardiogr. 2011;24:687-692. doi:10.1016/j.echo.2011.03.008

McLure LE Peacock AJ. Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension. Eur Respir J. 2009;33:1454-1466. doi:10.1183/09031936.00139907

Peyrou J Chauvel C Pathak A Simon M Dehant P Abergel E. Preoperative right ventricular dysfunction is a strong predictor of 3 years survival after cardiac surgery. Clin Res Cardiol. 2017;106:734-742. doi:10.1007/s00392-017-1117-y

Loh E Stamler JS Hare JM Loscalzo J Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation. 1994;90:2780-2785.

Califf RM Adams KF McKenna WJ et al . A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1997;134:44-54.

Palmer SM Robinson LJ Wang A Gossage JR Bashore TM Tapson VF. Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. Chest. 1998;113:237-240. doi:10.1378/chest.113.1.237

Costard-Jäckle A Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 1992;19:48-54. doi:10.1016/0735-1097(92)90050-W

Granton J Mercier O De Perrot M. Management of severe pulmonary arterial hypertension. Semin Respir Crit Care Med. 2013;34:700-713. doi:10.1055/s-0033-1356460

Sabato LA Salerno DM Moretz JD Jennings DL. Inhaled pulmonary vasodilator therapy for management of right ventricular dysfunction after left ventricular assist device placement and cardiac transplantation. Pharmacotherapy. 2017;37:944-955. doi:10.1002/phar.1959

Thunberg CA Morozowich ST Ramakrishna H. Inhaled therapy for the management of perioperative pulmonary hypertension. Ann Card Anaesth. 2015;18:394-402. doi:10.4103/0971-9784.159811

Rao V Ghadimi K Keeyapaj W Parsons CA Cheung AT. Inhaled nitric oxide (iNO) and inhaled epoprostenol (iPGI2) use in cardiothoracic surgical patients: is there sufficient evidence for evidence-based recommendations? J Cardiothorac Vasc Anesth. 2018;32:1452-1457. doi:10.1053/j.jvca.2017.12.014

Elmi-Sarabi M Deschamps A Delisle S et al . Aerosolized vasodilators for the treatment of pulmonary hypertension in cardiac surgical patients: a systematic review and meta-analysis. Anesth Analg. 2017;125:393-402. doi:10.1213/ANE.0000000000002138

Ruth BK Bilchick KC Mysore MM et al . Increased pulmonary-systemic pulse pressure ratio is associated with increased mortality in group 1 pulmonary hypertension [published online June 21, 2018]. Heart Lung Circ. doi:10.1016/j.hlc.2018.05.199

Li M Dumesnil JG Mathieu P Pibarot P. Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement. J Am Coll Cardiol. 2005;45:1034-1040. doi:10.1016/j.jacc.2004.10.073

Rich S Rabinovitch M. Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension. Circulation. 2008;118:2190-2199. doi:10.1161/CIRCULATIONAHA.107.723007

Jiang G Li B Zhang G Xu E Liu Y Xu Z. Effects of sildenafil on prognosis in patients with pulmonary hypertension after left-sided valvular surgery. Heart Lung Circ. 2014;23:680-685. doi:10.1016/j.hlc.2013.12.014

Bermejo J Yotti R García-Orta R et al . Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial. Eur Heart J. 2018;39:1255-1264. doi:10.1093/eurheartj/ehx700

Hensley MK Levine A Gladwin MT Lai YC. Emerging therapeutics in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2018;314:L769-L781. doi:10.1152/ajplung.00259.2017

Simonneau G. Robbins I. M. Beghetti M. Channick R. N. Delcroix M. Denton C. P. et al . (2009). Updated Clinical Classification of Pulmonary Hypertension. JAC, 54(1), S43-S54. http://doi.org/10.1016/j.jacc.2009.04.012